crohn's glp 1 GLP-1 RAs and Disease Semaglutide & Crohn's Disease: Safety

Four individual GLP-1 receptor agonists have now demonstrated MACE superiority in their dedicated cardiovascular outcome trials: Liraglutide: LEADER trial Semaglutide: SUSTAIN-6 and the landmark SELECT trial Dulaglutide: REWIND trial Albiglutide: HARMONY trial The SELECT trial deserves special attention because it broke entirely new ground

Recalls & Warnings January 24, 2003 FTC Challenges Weight-loss Claims for Slim Down Solution The Federal Trade Commission today charged Slim Down Solution, LLC, Maderia Management, Inc., and several related companies and individuals with using false and unsubstantiated claims in the marketing and advertising of "Slim Down Solution" - a purported weight-loss product

Medicare Advantage plans must cover all the same services as Original Medicare and often include additional benefits, including prescription drugs

Macrophage immunometabolism: where are we (Going)

What it won't do is replace sleep, sunscreen, hydration, and basic skin care

A., Donovan, J